News & Press
Abbott acquires Synaptic Medical for $380M to expand pain neuromodulation portfolio
Wall Street Journal4/1/2026·04/01/26🌐 USA
Summary
Abbott agreed to acquire Synaptic Medical, a developer of dorsal root ganglion stimulation systems for complex regional pain syndrome, for $380M upfront plus $120M in milestones.
Why it matters
Abbott paying 9x revenue for Synaptic validates DRG stimulation as a premium commercial segment and sets valuation benchmarks for other pain neuromodulation startups considering exits.
#Chronic Pain#Deep Brain Stimulation#Industry#Neurostimulation
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in